Arcturus Therapeutics Holdings (ARCT) Share-based Compensation (2018 - 2025)
Historic Share-based Compensation for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $5.7 million.
- Arcturus Therapeutics Holdings' Share-based Compensation fell 3965.03% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year decrease of 2709.15%. This contributed to the annual value of $38.0 million for FY2024, which is 963.66% up from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Share-based Compensation is $5.7 million, which was down 3965.03% from $6.2 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' Share-based Compensation's 5-year high stood at $10.1 million during Q1 2024, with a 5-year trough of $5.7 million in Q3 2025.
- In the last 5 years, Arcturus Therapeutics Holdings' Share-based Compensation had a median value of $7.5 million in 2021 and averaged $7.9 million.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Share-based Compensation soared by 72296.82% in 2021, and later crashed by 3965.03% in 2025.
- Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Share-based Compensation stood at $7.5 million in 2021, then dropped by 13.14% to $6.5 million in 2022, then skyrocketed by 34.99% to $8.8 million in 2023, then grew by 1.91% to $9.0 million in 2024, then tumbled by 36.22% to $5.7 million in 2025.
- Its Share-based Compensation stands at $5.7 million for Q3 2025, versus $6.2 million for Q2 2025 and $6.7 million for Q1 2025.